Somatostatin analogue octreotide as partner of docetaxel in androgen-independent prostate cancer therapy Posted on 9 dicembre 2014 Lo Nigro C., Lattanzio L., Monteverde M., Tonissi F., Merlano M.: “Somatostatin analogue octreotide as partner of docetaxel in androgen-independent prostate cancer therapy”, 2010 Genitourinary Cancers Symposium, San Fransisco, CA, USA, 5-7 marzo 2010.